IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Restricted Medications Non-Formulary
×
Search results for:
oxyMORphone
oxyMORphone
Brand names:
Opana, Opana ER
Form
Strength
TABLET, EXTENDED RELEASE, ORAL
10 mg; 20 mg
TABLET, ORAL
10 mg
Display
Opioid Agonists
Class:
280808
Medication comments:
ANTIDOTE: naloxone (Narcan)
Equianalgesic Dosing
Last updated:
Sep. 11, 2023
Restricted Medications
Non-Formulary
Black Box Warnings
Abuse/diversion potential; drug dependence
Look-Alike/Sound-Alike
oxyMORphone confused with HYDROmorphone, oxyCODONE, OxyCONTIN
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
Class II